FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart Rhythm Association (EHRA) conference in Paris, France from April 12-14, 2026. EHRA is one of several conferences supported by the European Society of Cardiology whose mission is to reduce the number of people with cardiovascular diseases by connecting cardiovascular health professionals around the world to disseminate the latest knowledge, innovations and guidelines. As a community, they work together to empower healthcare providers to transform cardiovascular care from a privilege to a universal right. David Jenkins, CEO of Catheter Precision, says, “Conferences continue to be a top priority for Catheter Precision. It is at these events that...

VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company“) (CSE: GXP | OTC: GXPLF | FRA: HW3) is pleased to announce the completion of an integrated 3D multi‑physics inversion and machine‑learning‑assisted lithology modelling program (the “Program”) at its Carpenter Lake Uranium Project (“Carpenter Lake” or the “Project”), located along the Cable Bay Shear Zone (“CBSZ”) on the southern margin of the Athabasca Basin, northern Saskatchewan. The work was completed by Convolutions Geoscience Corp. (“Convolutions”) in collaboration with Computational Geosciences Inc. (“CGI”), who served as independent inversion specialists and developers of the Geophysics‑Informed Lithology Interpolation (“GILI”) platform (Please see Figure 1). Russell Starr, CEO...

SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced that Artiva management will participate in a panel as well as a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 2:15 p.m. EDT. To access the audio webcast and subsequent archived recording of this and other company presentations, please visit the Investors section of Artiva’s website. The archived audio webcast will remain available for replay on Artiva’s website for 90 days. About Artiva BiotherapeuticsArtiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and...

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its first quarter 2026 financial results on Wednesday, April 29, 2026 at 10:00 a.m. Eastern Time. The Company’s first quarter financial results will be released after the market closes on Tuesday, April 28, 2026. During the conference call, Company officers will review first quarter 2026 performance, discuss recent events and conduct a question-and-answer period. To register for the call, please use the following link:   https://register-conf.media-server.com/register/BI073b00720c8d4549af7fd43ddcdbcb97 After you register, you will receive a dial-in number and unique pin. The Company will also post a link in the Stockholders’ section on ARI’s...

Preclinical milestone for selection and approval of first compound for lead optimization has been achieved Further development validates the potential intended mechanistic effect of CUE-501 for T cell-mediated targeted depletion of specific B cells to address autoimmune and inflammatory diseasesBOSTON, April 08, 2026 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage memory T cell subsets to deplete pathogenic B cells for the potential treatment of autoimmune and inflammatory diseases, today announced that it will receive a $7.5 million preclinical milestone payment under its collaboration and license agreement with Boehringer Ingelheim following Boehringer Ingelheim’s selection and approval of its first compound...

Maryland operations advancing with first patients seen following recent Medicaid and Medicare in-network expansion  Dr. Suzanne Caccamese has been appointed Maryland Medical Lead, bringing clinical training from Penn State College of Medicine and academic and clinical leadership experience from Towson University, MedStar and the University of Maryland The expansion underscores Rocket Doctor’s U.S. growth strategy, advancing access to high-quality, technology-enabled care in underserved and high-demand marketsVancouver, BC, April 08, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly owned digital health platform and marketplace have officially commenced patient care operations in Maryland, marking a significant milestone in...

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended March 31, 2026 on Tuesday, May 5, 2026 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Wednesday, May 6, 2026. All interested parties may participate in the conference call by dialing (800) 245-3047 approximately 5-10 minutes prior to the call, international callers should dial (203) 518-9765. Participants should reference SLR Investment Corp. and Conference ID: SLRC1Q26. A telephone replay will be available until May 20, 2026 and can be accessed by dialing (800) 695-1624. International callers should dial (402) 530-9026. This conference call will also be broadcast...

Earnings Release and Conference Call Scheduled for May 6, 2026 SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN) today announced that it will issue its first quarter 2026 earnings report after the market closes on Wednesday, May 6, 2026. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at https://investors.sunrun.com or over the phone by dialing (877) 407-5989 (toll-free) or (201) 689-8434 (toll). An audio replay will be available following the call on the Sunrun Investor Relations website for approximately one month. A transcript of the conference call will also be posted to the Sunrun Investor Relations website the following day. About SunrunSunrun Inc. (Nasdaq: RUN) is America’s...

CHASKA, Minn., April 08, 2026 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 12th Annual American Biomanufacturing Summit. The conference will take place April 14 – 15, 2026, in San Francisco, CA. Details regarding Lifecore’s participation are as follows:12th Annual American Biomanufacturing SummitDetails: Lifecore team will be present to discuss process development and manufacturing services for injectables programs.Booth number: 41 Conference Dates: April 14 – 15, 2026Location: Hyatt Regency San Francisco Airport, San Francisco, CAIf you are interested in meeting with Lifecore during this event, please reach out to us at: cdmo@lifecore.com. About...